|
US4391904A
(en)
|
1979-12-26 |
1983-07-05 |
Syva Company |
Test strip kits in immunoassays and compositions therein
|
|
US4296206A
(en)
|
1980-04-30 |
1981-10-20 |
United States Of America |
Irreversible anti-glucocorticoids
|
|
US4978657A
(en)
|
1981-01-09 |
1990-12-18 |
Roussel Uclaf |
Novel 11β-substituted-19-nor-steroids
|
|
ZA8231B
(en)
|
1981-01-09 |
1982-11-24 |
Roussel Uclaf |
New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
|
|
FR2528434B1
(fr)
|
1982-06-11 |
1985-07-19 |
Roussel Uclaf |
Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
|
|
FR2639045B2
(fr)
|
1982-03-01 |
1994-07-29 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto-delta-4,9-19-nor steroides et leur application comme medicaments
|
|
FR2522328B1
(fr)
|
1982-03-01 |
1986-02-14 |
Roussel Uclaf |
Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
|
|
DE3438994A1
(de)
|
1984-10-22 |
1986-04-24 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
Antigestagene, glukokortikoide und prostaglandine zur geburtseinleitung oder fuer den schwangerschaftsabbruch
|
|
FR2576025B1
(fr)
|
1985-01-14 |
1987-01-23 |
Roussel Uclaf |
Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
|
|
AU580843B2
(en)
|
1985-02-07 |
1989-02-02 |
Schering Aktiengesellschaft |
11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
|
|
DE3506785A1
(de)
|
1985-02-22 |
1986-08-28 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US5382661A
(en)
|
1985-09-12 |
1995-01-17 |
The Upjohn Company |
Pyrazinylpiperazinyl steroids
|
|
FR2598421B1
(fr)
|
1986-05-06 |
1988-08-19 |
Roussel Uclaf |
Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
|
|
DE3761308D1
(de)
|
1986-07-23 |
1990-02-08 |
Akzo Nv |
18-phenylestrane-derivate.
|
|
DE3625315A1
(de)
|
1986-07-25 |
1988-01-28 |
Schering Ag |
11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
US4861763A
(en)
|
1986-09-17 |
1989-08-29 |
Research Triangle Institute |
17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use
|
|
US4774236A
(en)
|
1986-09-17 |
1988-09-27 |
Research Triangle Institute |
17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them
|
|
US5071773A
(en)
|
1986-10-24 |
1991-12-10 |
The Salk Institute For Biological Studies |
Hormone receptor-related bioassays
|
|
US4921638A
(en)
|
1986-11-05 |
1990-05-01 |
The Upjohn Company |
17β-cyano-9α,17α-dihydroxyandrost-4-en-3-one
|
|
DE3708942A1
(de)
|
1987-03-18 |
1988-09-29 |
Schering Ag |
19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
DE3723788A1
(de)
|
1987-07-16 |
1989-01-26 |
Schering Ag |
11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate
|
|
FR2618783B1
(fr)
|
1987-07-30 |
1991-02-01 |
Roussel Uclaf |
Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
|
|
BE1004905A4
(fr)
|
1987-12-30 |
1993-02-23 |
Roussel Uclaf |
Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
|
DE3820948A1
(de)
|
1988-06-16 |
1989-12-21 |
Schering Ag |
10ss, 11ss-ueberbrueckte steroide
|
|
US4954490A
(en)
|
1988-06-23 |
1990-09-04 |
Research Triangle Institute |
11 β-substituted progesterone analogs
|
|
US5348729A
(en)
|
1988-11-30 |
1994-09-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Evaluative means for detecting inflammatory reactivity
|
|
DD289541A5
(de)
|
1989-08-04 |
1991-05-02 |
��@�K@�������������@�K@��������������@��������k�� |
Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen
|
|
US5276023A
(en)
|
1989-08-08 |
1994-01-04 |
Roussel Uclaf |
19-nor-steroid esters
|
|
FR2651233B1
(fr)
|
1989-08-23 |
1991-12-13 |
Roussel Uclaf |
Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
|
|
US5173405A
(en)
|
1990-01-23 |
1992-12-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of arsenite to reversibly block steroid binding to glucocorticoid receptors in the presence of other steroid receptors
|
|
US5616458A
(en)
|
1990-03-14 |
1997-04-01 |
Board Of Regents, University Of Tx System |
Tripterygium wilfordii hook F extracts and components, and uses thereof
|
|
DE4042004A1
(de)
|
1990-12-22 |
1992-06-25 |
Schering Ag |
14(beta)-h-, 14- u. 15-en-11(beta)-aryl-4-estrene
|
|
US5215916A
(en)
|
1991-06-19 |
1993-06-01 |
The United States Of America As Represented By The Department Of Health & Human Services |
Super glucocorticoid receptors: receptors with increased affinity and specificity for glucocorticoid steriods
|
|
US5439913A
(en)
|
1992-05-12 |
1995-08-08 |
Schering Aktiengesellschaft |
Contraception method using competitive progesterone antagonists and novel compounds useful therein
|
|
DE69500542T2
(de)
|
1994-05-19 |
1998-01-02 |
Akzo Nobel Nv |
11,21-Bisphenyl-19-nor-pregnan Derivate
|
|
US6051573A
(en)
|
1994-06-28 |
2000-04-18 |
Alcon Laboratories, Inc. |
Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists
|
|
US5696130A
(en)
|
1994-12-22 |
1997-12-09 |
Ligand Pharmaceuticals Incorporated |
Tricyclic steroid receptor modulator compounds and methods
|
|
EP1043325B1
(en)
|
1994-12-22 |
2004-06-16 |
Ligand Pharmaceuticals Incorporated |
Steroid receptor modulator compounds and methods
|
|
IL118974A
(en)
|
1995-08-17 |
2001-09-13 |
Akzo Nobel Nv |
History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
|
|
WO1998027986A1
(en)
|
1996-12-24 |
1998-07-02 |
Zymogenetics, Inc. |
Treatment agents and methods for treating type ii diabetes and symptoms of type ii diabetes
|
|
EP0903146A1
(en)
|
1997-09-23 |
1999-03-24 |
Applied Research Systems ARS Holdings N.V. |
21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
|
|
DE10038639A1
(de)
|
2000-07-28 |
2002-02-21 |
Schering Ag |
Nichtsteroidale Entzündungshemmer
|
|
IL146057A
(en)
|
2000-10-27 |
2007-09-20 |
Pfizer Prod Inc |
A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
|
|
WO2003043640A2
(en)
|
2001-11-23 |
2003-05-30 |
Akzo Nobel N.V. |
Treatment of major depressive disorder using glucocorticoid receptor antagonists
|
|
AU2005222421B2
(en)
|
2004-03-09 |
2010-09-23 |
Corcept Therapeutics, Inc. |
Fused ring azadecalin glucocorticoid receptor modulators
|
|
US20060205700A1
(en)
*
|
2005-03-09 |
2006-09-14 |
May Flavia S |
Non invasive method for prevention and treatment of cancer
|
|
ES2531040T3
(es)
|
2009-05-12 |
2015-03-10 |
Corcept Therapeutics Inc |
Formas sólidas y procedimiento de preparación
|
|
KR20180026795A
(ko)
|
2009-06-12 |
2018-03-13 |
악셀레론 파마 인코포레이티드 |
절두된 ＡｃｔＲＩＩＢ-ＦＣ 융합 단백질
|
|
US8710035B2
(en)
|
2010-03-24 |
2014-04-29 |
The University Of Chicago |
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
|
|
DK2685827T3
(en)
*
|
2011-03-18 |
2016-05-17 |
Corcept Therapeutics Inc |
PYRIMIDIN -cyclohexyl- glucocorticoid receptor MODULATORS
|
|
EP3111950B1
(en)
|
2012-02-24 |
2021-08-25 |
The University of Chicago |
Methods and compositions related to glucocorticoid receptor antagonism and prostate cancer
|
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
|
PT4119561T
(pt)
|
2012-05-25 |
2024-09-30 |
Corcept Therapeutics Inc |
Moduladores de recetores de glucocorticoides de azadecalina fundida com heteroaril-cetona
|
|
US8986677B2
(en)
|
2012-07-30 |
2015-03-24 |
Pop Test Cortisol Llc |
Therapeutic compositions and methods
|
|
FI3848027T3
(fi)
*
|
2013-11-25 |
2023-05-04 |
Corcept Therapeutics Inc |
Oktahydrofuusioituja atsadekaliiniglukokortikoidireseptorin modulaattoreita
|
|
CN107530435A
(zh)
|
2015-03-02 |
2018-01-02 |
科赛普特治疗学股份有限公司 |
使用糖皮质激素受体拮抗剂和生长抑素治疗acth分泌型肿瘤
|
|
IL297201A
(en)
*
|
2016-03-01 |
2022-12-01 |
Corcept Therapeutics Inc |
Use of glucocorticoid receptor modulators to increase the activity of checkpoint inhibitors
|
|
WO2018209142A2
(en)
*
|
2017-05-10 |
2018-11-15 |
Corcept Therapeutics, Inc. |
Octahydro azadecalin formulations
|
|
AU2018289307B2
(en)
*
|
2017-06-20 |
2024-02-01 |
Corcept Therapeutics, Inc. |
Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
|